Arca biopharma reports q3 loss per share of $0.76

Arca biopharma announces third quarter 2019 financial results and provides corporate update.q3 loss per share $0.76.cash and cash equivalents were $9.6 million as of september 30, 2019.

ABIO Ratings Summary

ABIO Quant Ranking